pennystocktracker
08-24-2009, 04:30 PM
SUPERB……Cell Therapeutics, Inc (NASDAQ:CTIC) is among the gainers on NASDAQ in the early morning trade. The stock is up 5.9% to $1.79 with over 4.96 million shares being traded within few minutes of trade. Today (August 24, 2009), Cell Therapeutics, Inc announced that the U.S. Food and Drug Administration has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL)……
check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!
check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!